Atlas Trials

Intranasal Dexmedetomidine Versus Oral Midazolam as Premedication for Propofol Sedation in Pediatric Patients Undergoing Magnetic Resonance Imaging

Clinical trial NCT05192629 · UNKNOWN

Trial details

NCT number
NCT05192629
Sponsor
Brugmann University Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
MRIPediatric SedationMidazolamDexmedetomidine
Start date
2022-03-09
Primary completion
2023-06-15
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.